HS/CN kodas 30021095 EUDR parengimui yra nepatenka į taikymo sritį.
Blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);Blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);Blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001) Indeksuotas taikymo srities variklis šiam kodui grąžina Out of scope. No Annex I scope match was found for this indexed CN code.
Kodėl šis informacinis puslapis pateikia tokį atsakymą.
- Kodo aprašymas
- Blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);Blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);Blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)
- I priedo pagrindas
- Nėra tiesioginio I priedo įrašo
- Šaltinio pagrindas
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Aukštesnio, žemesnio lygio ir gretimos eilutės.
Žinyno rodinys skirtas informacinei navigacijai. Norėdami patikrinti kitą kodą kaip veiksmą, naudokite tikrintuvą.
Ką tai reiškia parengimui.
Ši eilutė dabartiniame taikymo srities rezultate tiesiogiai nesukelia įrodymų rinkimo.